Tumors with intrahepatic bile duct differentiation in cirrhosis: Implications on outcomes after liver transplantation

Marcelo E. Facciuto*, Manoj K. Singh, Nir Lubezky, Motaz A. Selim, Dorothy Robinson, Leona Kim-Schluger, Sander Florman, Stephen C. Ward, Swan N. Thung, Mariaisabel Fiel, Thomas D. Schiano

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

61 Scopus citations


Background. The role of liver transplantation (LT) in the management of cirrhotic patients with tumors exhibiting intrahepatic bile duct differentiation remains controversial. The objective of this study was to characterize the spectrum of these tumors and analyze post-LT outcomes.

Methods. Retrospective pathology database search of explant histology analysis of liver transplants between April 1993 and November 2013.

Results. Thirty-two patients were analyzed, 75% were men with a mean age of 60 years. Seven patients had nodules demonstrating intrahepatic cholangiocarcinoma (I-CCA), nine had I-CCA nodules occurring concomitantly with hepatocellular carcinoma (HCC), and 16 had mixed HCC-CCA nodules. The median number of tumors was 1 and size was 2.5 cm. Overall patient survival post-LT at 1 and 5 years was 71% and 57%, respectively. Patients within Milan criteria, especially with I-CCA features, showed a 5-year tumor recurrence rate (10%) and 5-year survival rate (78%) comparable with other patients having HCC within Milan criteria.

Conclusion. This series showed that patients with CCA within Milan criteria may be able to achieve acceptable long-term post-LT survival.

Original languageEnglish
Pages (from-to)151-157
Number of pages7
Issue number1
StatePublished - 15 Jan 2015
Externally publishedYes


Dive into the research topics of 'Tumors with intrahepatic bile duct differentiation in cirrhosis: Implications on outcomes after liver transplantation'. Together they form a unique fingerprint.

Cite this